Rene Gomez Esquivel, MD
Gastroenterology · Tampa, FLNPI 1295080794
Payments from drug & device makers
Across 58 payments — averaging $138.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fujifilm Healthcare Americas Corporation$3K
- Boston Scientific$1K
- Cook Medical LLC$1K
- Medtronic$843
- Olympus Corporation Of The Americas$625
- Cook Incorporated$500
- plus $570 from 6 others
What the payments were for
- Consulting fees$3,10138%
- Speaking & faculty fees$5006%
- Travel & lodging$5987%
- Food & beverage$3,85548%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fujifilm Healthcare Americas Corporation | 1 | $3,101 |
| Boston Scientific | 20 | $1,356 |
| Cook Medical LLC | 14 | $1,060 |
| Medtronic | 7 | $843 |
| Olympus Corporation Of The Americas | 6 | $625 |
| Cook Incorporated | 1 | $500 |
| Lumendi LLC | 2 | $186 |
| Aries Pharmaceuticals, Inc. | 1 | $105 |
| Amgen | 1 | $102 |
| Steris Corporation | 1 | $101 |
| Olympus America Inc. | 3 | $42 |
| Biocompatibles, Inc. | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FUJIFILM$3,101
- Olympus EMR & ESD Devices$579
- Olympus Hemostasis Devices$579
- Olympus EndoTherapy Accessories$579
- EndoFlip$397
- Fusion Quattro$280
- GI Genius$144
- EXALT Model D$132
- EXALT$128
- PillCam$127
- DiLumen$119
- EXALT MODEL D CONTROLLER$115
- SPYGLASS$106
- FUSION$105
- ELEVIEW$105
- TRUFREEZE$101
How this compares
$8,054 in reported general payments places this provider in the 70th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 24 | $66,875 |
| CreonLipase/Protease/Amylase | 20 | $54,481 |
| ZenpepLipase/Protease/Amylase | 11 | $39,366 |
| Omeprazole | 54 | $703 |
| Pantoprazole Sodium | 46 | $513 |
| Famotidine | 14 | $294 |
| Dicyclomine Hcl | 16 | $159 |
| Ondansetron Hcl | 11 | $61 |
| Levofloxacin | 12 | $18 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Tampa
- Alan WeintraubTampa$4.7M
- Angel RosarioTampa$1.4M
- Howard SchwartzTavernier$38.8M
- Guy NeffSarasota$17.6M
- Syed LateefClermont$6.4M
- Jeffrey SchneiderCoral Springs$6M
- Zaid RanaMiami$5.4M
- David NelsonGainesville$5.2M
- Curtis FreedlandNew Port Richey$4.5M
- Paul HellsternCrystal River$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.